Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adicet Bio
Biotech
Adicet Bio CAR-T sparks lupus remissions in early-stage trial
Adicet's prula-cel sent more than half of patients’ lupus into remission, without the dangerous side effects that recently rocked Big Pharma.
Darren Incorvaia
Sep 28, 2026 6:45am
Cell therapy biotech Adicet sheds 30% of staffers
Jul 24, 2025 10:20am
Adicet's gamma delta CAR-T therapy readout tees up phase 2 trial
Jun 6, 2022 11:14am
Adicet soars on early responses to gamma delta CAR-T therapy
Dec 6, 2021 8:30am
Adicet inks resTORbio reverse merger, plots financing
Apr 30, 2020 8:00am
Adicet Bio reels in $80M to push lymphoma program into clinic
Oct 3, 2019 7:15am
